FAM111B knockdown attenuates tumorigenesis of ovarian cancer via the downregulation of MYC
Abstract Background Ovarian cancer, a prevalent malignancy with the highest fatality rate among gynecological cancers, continues to face challenges in the development of effectively targeted therapeutic approaches. While the FAM111B gene has been implicated in various cancer types, its specific role...
Saved in:
| Main Authors: | Guoyu Yu, Fang Wei, Wanying Li, Qiuyun Guo, Lihong Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14740-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FAM111B Overexpression and Immune Cell Infiltration: Implications for Ovarian Cancer Immunotherapy
by: Wanying Li, et al.
Published: (2025-05-01) -
FAM111B and FANCD2, a dual expression signature, defines a distinct phenotype of pancreatic cancer
by: Fang Wei, et al.
Published: (2025-05-01) -
Alteration in expression and subcellular localization of the androgen receptor- regulated FAM111A protease is associated with emergence of castration resistant prostate cancer
by: Maria Malvina Tsamouri, et al.
Published: (2025-08-01) -
Modified screening of MYC promotor region elements using the CRISPR library in ovarian cancer
by: Akiko Yamamoto, et al.
Published: (2025-04-01) -
FAM64A silencing inhibits the proliferation, migration, invasion, and epithelial-mesenchymal transition in ovarian cancer cells via activating Hippo pathway
by: Jianxiu Luo, et al.
Published: (2025-06-01)